{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_notes_@count in root_notes_@count (approximate match)
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Approved Rx
(1977)
First approved in 1977
Class:
POLYMER
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(20) weight control alginic acid
Source URL:
First approved in 1959
Source:
ANDA205126
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
M003
(2024)
Source URL:
First approved in 2018
Source:
21 CFR 333E
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y
Source URL:
Class:
POLYMER
Status:
Investigational
Source:
NCT03135015: Phase 1 Interventional Completed Insulin Resistance, Diabetes
(2017)
Source URL:
Class:
STRUCTURALLY DIVERSE